107 related articles for article (PubMed ID: 8359011)
1. A comparison of the in vitro postantibiotic effect of meropenem and imipenem versus selected enterobacteriaceae and other pathogens.
Nadler HL; Sheikh W
Diagn Microbiol Infect Dis; 1993 Jul; 17(1):71-3. PubMed ID: 8359011
[TBL] [Abstract][Full Text] [Related]
2. The postantibiotic effect of meropenem and imipenem on selected bacteria.
Nadler HL; Pitkin DH; Sheikh W
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():225-31. PubMed ID: 2509416
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of three carbapenem antibiotics. Comparative studies with biapenem (L-627), imipenem, and meropenem against aerobic pathogens isolated worldwide.
Hoban DJ; Jones RN; Yamane N; Frei R; Trilla A; Pignatari AC
Diagn Microbiol Infect Dis; 1993; 17(4):299-305. PubMed ID: 8112045
[TBL] [Abstract][Full Text] [Related]
4. The comparative inhibitory and bactericidal activities of meropenem and imipenem against Acinetobacter spp. and Enterobacteriaceae resistant to second generation cephalosporins.
MacGowan AP; Bowker KE; Bedford KA; Holt HA; Reeves DS; Hedges A
J Antimicrob Chemother; 1995 Feb; 35(2):333-7. PubMed ID: 7759397
[TBL] [Abstract][Full Text] [Related]
5. Comparison of in vitro activity of doripenem, imipenem and meropenem against clinical isolates of Enterobacteriaceae, Pseudomonas and Acinetobacter in Southern Poland.
Drzewiecki A; Bulanda M; Talaga K; Sodo A; Adamski P
Pol Przegl Chir; 2012 Sep; 84(9):449-53. PubMed ID: 23241660
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the vitek 2 AST-N269 card for detection of meropenem resistance in imipenem-susceptible meropenem-resistant Enterobacteriaceae.
Koizumi A; Kasahara K; Komatsu Y; Ui K; Mizuno F; Nakayama A; Mikasa K
J Clin Microbiol; 2013 Nov; 51(11):3908. PubMed ID: 23966492
[No Abstract] [Full Text] [Related]
7. Comparative in vitro antibacterial activity of the new carbapenem meropenem (SM-7338).
Visser MR; Hoepelman IM; Beumer H; Rozenberg-Arska M; Verhoef J
Eur J Clin Microbiol Infect Dis; 1989 Dec; 8(12):1061-4. PubMed ID: 2695328
[TBL] [Abstract][Full Text] [Related]
8. [in vitro activity of carbapenems against Enterobacteriaceae and Pseudomonas aeruginosa hyperproducers of group 1 chromosomal beta-lactamases].
Martínez-Beltrán J; Calderón C; Sierra MP; Alvarez M; Cantón R
Enferm Infecc Microbiol Clin; 1997 Sep; 15 Suppl 1():20-6. PubMed ID: 9410065
[TBL] [Abstract][Full Text] [Related]
9. Comparative in-vitro activity of meropenem against selected pathogens from hospitalized patients in The Netherlands. MASTIN Study Group.
Endtz HP; van Dijk WC; Verbrugh HA
J Antimicrob Chemother; 1997 Feb; 39(2):149-56. PubMed ID: 9069534
[TBL] [Abstract][Full Text] [Related]
10. Comparative in vitro activity of meropenem versus other extended-spectrum antimicrobials against randomly chosen and selected resistant clinical isolates tested in 26 North American centers.
Pitkin DH; Sheikh W; Nadler HL
Clin Infect Dis; 1997 Feb; 24 Suppl 2():S238-48. PubMed ID: 9126699
[TBL] [Abstract][Full Text] [Related]
11. Comparative Activity of Carbapenem Testing (COMPACT) study in Germany.
Valenza G; Seifert H; Decker-Burgard S; Laeuffer J; Morrissey I; Mutters R;
Int J Antimicrob Agents; 2012 Mar; 39(3):255-8. PubMed ID: 22230334
[TBL] [Abstract][Full Text] [Related]
12. [Bactericidal activity and capacity for selection of mutants resistant to imipenmen and meropenem in strains of Proteus, Morganella and Providencia].
Villar HE; Longo L; Arena MF; Laurino G; Hoffman M
Enferm Infecc Microbiol Clin; 1998; 16(6):261-4. PubMed ID: 9763741
[TBL] [Abstract][Full Text] [Related]
13. Comparison of in vitro efficacy of ertapenem, imipenem and meropenem in the infections caused by the Enterobacteriaceae strains family.
Guzek A; Tomaszewski D; Rybicki Z; Truszczyński A; Barański M; Korzeniewski K
Anaesthesiol Intensive Ther; 2013; 45(2):67-72. PubMed ID: 23877897
[TBL] [Abstract][Full Text] [Related]
14. In vitro activity of polymyxin B plus imipenem, meropenem, or tigecycline against KPC-2-producing Enterobacteriaceae with high MICs for these antimicrobials.
Barth N; Ribeiro VB; Zavascki AP
Antimicrob Agents Chemother; 2015; 59(6):3596-7. PubMed ID: 25801560
[TBL] [Abstract][Full Text] [Related]
15. Comparative in-vitro activity of meropenem against clinical isolates including Enterobacteriaceae with expanded-spectrum beta-lactamases.
Chanal C; Sirot D; Chanal M; Cluzel M; Sirot J; Cluzel R
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():133-41. PubMed ID: 2808205
[TBL] [Abstract][Full Text] [Related]
16. In vitro activities of three carbapenems against recent bacterial isolates from severely ill patients at Swedish hospitals.
Fraenkel CJ; Ullberg M; Bernander S; Ericson E; Larsson P; Rydberg J; Törnqvist E; Melhus A
Scand J Infect Dis; 2006; 38(10):853-9. PubMed ID: 17008228
[TBL] [Abstract][Full Text] [Related]
17. Comparative in vitro activity of Meropenem, Imipenem and Piperacillin/tazobactam against 1071 clinical isolates using 2 different methods: a French multicentre study.
Joly-Guillou ML; Kempf M; Cavallo JD; Chomarat M; Dubreuil L; Maugein J; Muller-Serieys C; Roussel-Delvallez M
BMC Infect Dis; 2010 Mar; 10():72. PubMed ID: 20298555
[TBL] [Abstract][Full Text] [Related]
18. Meropenem: in-vitro activity and kinetics of activity against organisms of the Bacteroides fragilis group.
García-Rodriguez JA; García Sánchez JE; Trujillano I; Sánchez de San Lorenzo A
J Antimicrob Chemother; 1991 May; 27(5):599-606. PubMed ID: 1885418
[TBL] [Abstract][Full Text] [Related]
19. Antibacterial activity of meropenem against gram-negative bacteria with a permeability defect and against staphylococci.
Kitzis MD; Acar JF; Gutmann L
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():125-32. PubMed ID: 2808204
[TBL] [Abstract][Full Text] [Related]
20. Comparative in vitro antimicrobial activity of a new carbapenem, E1010, and tentative disc diffusion test interpretative criteria.
Fuchs PC; Barry AL; Brown SD
J Antimicrob Chemother; 2001 Jul; 48(1):23-8. PubMed ID: 11418509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
